Top

Published in:

01-12-2011

Acute Exposure to 50-Hz Magnetic Fields Increases Interleukin-6 in Young Healthy Men

Authors: Brahim Selmaoui, Jacques Lambrozo, Linda Sackett-Lundeen, Erhard Haus, Yvan Touitou

Published in: Journal of Clinical Immunology | Issue 6/2011

Abstract

Some epidemiologic studies have suggested that extremely low frequency magnetic fields might affect human health and, in particular, that the incidence of certain types of cancer might increase among individuals living or working in environments exposed to such fields. This study is part of a broad study we conducted in humans. The study presented here was designed to look for possible effects of acute exposure to 50-Hz magnetic fields (10 μT) on the interleukin 1 beta (IL-1β), interleukin 2 (IL-2), interleukin 6 (IL-6), interleukin-1 receptor antagonist (IL-1RA), and the interleukin-2 receptor (IL-2R) production. Thirty-two young men (20–30 years old) were divided into two groups (sham-exposed or control group and exposed group) of 16 subjects each. All subjects participated in two 24-h experiments to evaluate the effects of both continuous and intermittent (1 h “off” and 1 h “on” with the field switched “on” and “off” every 15 s) exposure to linearly polarized magnetic fields. The subjects were exposed to the magnetic field from 2300 to 0800 while recumbent. Blood samples were collected during each session at 11:00, 17:00, 22:00, 01:00, 04:00, 06:00, and 08:00. Results showed that exposure to 50-Hz magnetic fields (10 μT) significantly increases IL-6 when subjects were exposed to an intermittent magnetic field. However, no effect has been observed on interleukin IL-1β, IL-2, IL-1RA, and IL-2R.

Wertheimer N, Leeper E. Electrical wiring configurations and childhood cancer. Am J Epidemiol. 1979;109(3):273–84.PubMed

Demers PA, Thomas DB, Rosenblatt KA, Jimenez LM, McTiernan A, Stalsberg H, et al. Occupational exposure to electromagnetic fields and breast cancer in men. Am J Epidemiol. 1991;134(4):340–7.PubMed

Olsen JH, Nielsen A, Schulgen G. Residence near high voltage facilities and risk of cancer in children. BMJ. 1993;307(6909):891–5.PubMedCrossRef

Savitz DA, Loomis DP. Magnetic field exposure in relation to leukemia and brain cancer mortality among electric utility workers. Am J Epidemiol. 1995;141(2):123–34. Erratum in: Am J Epidemiol. 1996. 144(2): 205.PubMed

Kheifets LI, Afifi AA, Buffler PA, Zhang ZW. Occupational electric and magnetic field exposure and brain cancer: a meta-analysis. J Occup Environ Med. 1995;37(12):1327–41.PubMedCrossRef

Fear NT, Simpson J, Roman E, United Kingdom Childhood Cancer Study Investigators. Childhood cancer and social contact: the role of paternal occupation (United Kingdom). Cancer Causes Control. 2005;16(9):1091–7.PubMedCrossRef

Miller AB, To T, Agnew DA, Wall C, Green LM. Leukemia following occupational exposure to 60-Hz electric and magnetic fields among Ontario electric utility workers. Am J Epidemiol. 1996;144(2):150–60.PubMed

Coogan PF, Clapp RW, Newcomb PA, Wenzl TB, Bogdan G, Mittendorf R, et al. Occupational exposure to 60-Hertz magnetic fields and risk of breast cancer in women. Epidemiology. 1996;7(5):459–64.PubMedCrossRef

Thériault G, Li CY. Risks of leukaemia among residents close to high voltage transmission electric lines. Occup Environ Med. 1997;54(9):625–8.PubMedCrossRef

10.

McBride ML, Gallagher RP, Theriault G, Armstrong BG, Tamaro S, Spinelli JJ, et al. Power-frequency electric and magnetic fields and risk of childhood leukemia in Canada. Am J Epidemiol. 1999;149:831–42.PubMed

11.

IARC: Non-ionizing radiation, PART 1: static and extremely low frequency (ELF) electric and magnetic field. Vol. 80, IARC Monographs on the evaluation of carcinogenic risks to humans, International Agency for Research on Cancer, Lyon, 2002.

12.

McLean JR, Stuchly MA, Mitchel RE, Wilkinson D, Yang H, Goddard M, et al. Cancer promotion in a mouse-skin model by a 60-Hz magnetic field: II. Tumor development and immune response. Bioelectromagnetics. 1991;12(5):273–87.PubMedCrossRef

13.

Tremblay L, Houde M, Mercier G, Gagnon J, Mandeville R. Differential modulation of natural and adaptive immunity in Fischer rats exposed for 6 weeks to 60 Hz linear sinusoidal continuous-wave magnetic fields. Bioelectromagnetics. 1996;17:373–83.PubMedCrossRef

14.

House RV, Ratajczak HV, Gauger JR, Johnson TR, Thomas PT, McCormick DL. Immune function and host defense in rodents exposed to 60-Hz magnetic fields. Fund Appl Toxicol. 1996;34:228–39.CrossRef

15.

House RV, McCormick DL. Modulation of natural killer cell function after exposure to 60 Hz magnetic fields: confirmation of the effect in mature B6C3F1 mice. Radiat Res. 2000;153:722–4.PubMedCrossRef

16.

Bonhomme-Faivre L, Marion S, Forestier F, Santini R, Auclair H. Effects of electromagnetic fields on the immune systems of occupationally exposed humans and mice. Arch Environ Health. 2003;58:712–7.PubMedCrossRef

17.

Gobba F, Bargellini A, Scaringi M, Bravo G, Borella P. Extremely low frequency-magnetic fields (ELF-EMF) occupational exposure and natural killer activity in peripheral blood lymphocytes. Sci Total Environ. 2009;407(3):1218–23.PubMedCrossRef

18.

Ramoni C, Dupuis ML, Vecchia P, Polichetti A, Petrini C, Bersani F, et al. Human natural killer cytotoxic activity is not affected by in vitro exposure to 50-Hz sinusoidal magnetic fields. Int J Radiat Biol. 1995;68:693–705.PubMedCrossRef

19.

Selmaoui B, Bogdan A, Auzeby A, Lambrozo J, Touitou Y. Acute exposure to 50-Hz magnetic field does not affect haematological and immune functions in young healthy men. A circadian study. Bioelectromagnetics. 1996;17:364–72.PubMedCrossRef

20.

Thun-Battersby S, Westermann J, Loscher W. Lymphocyte subset analyses in blood, spleen and lymph nodes of female Sprague–Dawley rats after short or prolonged exposure to a 50 Hz 100 microT magnetic field. Radiat Res. 1999;152:436–43.PubMedCrossRef

21.

Graham C, Sastre A, Cook MR, Gerkovich MM. All-night exposure to EMF does not alter urinary melatonin, 6-OHMS or immune measures in older men and women. J Pineal Res. 2001;31(2):109–13.PubMedCrossRef

22.

Ikeda K, Shinmura Y, Mizoe H, Yoshizawa H, Yoshida A, Kanao S, et al. No effects of extremely low frequency magnetic fields found on cytotoxic activities and cytokine production of human peripheral blood mononuclear cells in vitro. Bioelectromagnetics. 2003;24(1):21–31.PubMedCrossRef

23.

Cossarizza A, Angioni S, Petraglia F, Genezzani AR, Monti D, Capri M, et al. Exposure to low frequency pulsed electromagnetic fields increases interleukin-1 and interleukin-6 production by human peripheral blood mononuclear cells. Exp Cell Res. 1993;204(2):385–7.PubMedCrossRef

24.

Petrini C, Dupuis ML, Polichetti A, Ramoni C, Vecchia P. Tumor necrosis factor a and interferon g production by human peripheral blood mononuclear cells exposed in vitro to sinusoidal 50 Hz magnetic fields. Bioelectrochem Bioenerg. 1997;44:121–5.CrossRef

25.

Jonai H, Villanueva MB, Yasuda A. Cytokine profile of human peripheral blood mononuclear cells exposed to 50 Hz EMF. Ind Health. 1996;34:359–68.PubMedCrossRef

26.

Selmaoui B, Lambrozo J, Touitou Y. Magnetic fields and pineal function in human: evaluation of nocturnal acute exposure to extremely low frequency magnetic fields on serum melatonin and urinary 6-sulfatoxymelatonin circadian rhythms. Life Sci. 1996;58:1539–49.PubMedCrossRef

27.

Greenland S, Sheppard AR, Kaune WT, Poole C, Kelsh MA. A pooled analysis of magnetic fields, wire codes, and childhood leukemia. Childhood Leukemia-EMF Study Group. Epidemiology. 2000;11(6):624–34.PubMedCrossRef

28.

Ahlbom A, Day N, Feychting M, Roman E, Skinner J, Dockerty J, et al. A pooled analysis of magnetic fields and childhood leukaemia. Br J Cancer. 2000;83(5):692–8.PubMedCrossRef

29.

Swanson J, Kheifets L. Biophysical mechanisms: a component in the weight of evidence for health effects of power-frequency electric and magnetic fields. Radiat Res. 2006;165:470–8.PubMedCrossRef

30.

Perry MG, Kirwan JR, Jessop DS, Hunt LP. Overnight variations in cortisol, interleukin-6, tumor necrosis factor alpha and other cytokines in people rheumatoid arthritis. Ann Rheum Dis. 2009;68(1):63–8.PubMedCrossRef

31.

Jawa RS, Anillo S, Huntoon K, Baumann H, Kulaylat M. Analytic review: interleukin-6 in surgery, trauma, and critical care: part I: basic science. J Intensive Care Med. 2011;26(1):3–12.PubMedCrossRef

32.

Mastorakus G, Ilias I. Interleukin-6: a cytokine and/or a major modulator of the response to somatic stress. Ann NY Acad Sci. 2006;1088:373–81.CrossRef

33.

Spooren A, Kolmus K, Laureys G, Clinckers R, De Keyser J, Haegeman G, et al. Interleukin-6, a mental cytokine. Brain Res Rev. 2011;67(1–2):157–83.PubMedCrossRef

34.

Kristiansen OP, Mandrup-Poulsen T. Interleukin-6 and diabetes: the good, the bad, or the indifferent? Diabetes. 2005;54 Suppl 2:S114–24.PubMedCrossRef

35.

Dubiński A, Zdrojewicz Z. [The role of interleukin-6 in development and progression of atherosclerosis] (in Polish). Pol Merkur Lekarski. 2007;22(130):291–4.PubMed

36.

Dowlati Y, Herrmann N, Swardfager W, Liu H, Sham L, Reim EK, et al. A meta-analysis of cytokines in major depression. Biol Psychiatry. 2010;67(5):445–57.CrossRef

37.

Tackey E, Lipsky PE, Illei GG. Rationale for interleukin-6 blockade in systemic lupus erythematosus. Lupus. 2004;13(5):339–43.PubMedCrossRef

38.

Nishimoto N. Interleukin-6 in rheumatoid arthritis. Curr Opin Rheumatol. 2006;18(3):277–81.PubMedCrossRef

39.

Patel AM, Moreland LW. Interleukin-6 inhibition for treatment of rheumatoid arthritis: a review of tocilizumab therapy. Drug Des Devel Ther. 2010;4:263–78.PubMed

40.

Smith PC, Hobisch A, Lin DL, Culig Z, Keller ET. Interleukin-6 and prostate cancer progression. Cytokine Growth Factor Rev. 2001;12(1):33–40.PubMedCrossRef

41.

American Society of Clinical Oncology. Cancer patients typically have increased interleukin-6 levels. Am Soc Clin Oncol 2006 Annual Meeting. Abstracts 8632 and 8633, 2006

42.

Berger FG. The interleukin-6 gene: a susceptibility factor that may contribute to racial and ethnic disparities in breast cancer mortality. Breast Cancer Res Treat. 2005;88(3):281–5.CrossRef

43.

Barton BE. Interleukin-6 and new strategies for the treatment of cancer, hyperproliferative diseases and paraneoplastic syndromes. Expert Opin Ther Target. 2005;9(4):737–52.CrossRef

44.

Rose-John S, Waetzig GH, Scheller J, Grötzinger J, Seegert D. The IL-6/sIL-6R complex as a novel target for therapeutic approaches. Expert Opin Ther Target. 2007;11(5):613–24.CrossRef

45.

Scheller J, Rose-John S. Interleukin-6 and its receptor: from bench to bedside. Med Microbiol Immunol. 2006;195(4):173–83.PubMedCrossRef

46.

Barillé S, Bataille R, Amiot M. The role of interleukin-6 and interleukin-6/interleukin-6 receptor-alpha complex in the pathogenesis of multiple myeloma. Eur Cytokine Netw. 2000;11(4):546–51.PubMed

47.

Salerno S, Lo Casto A, Caccamo N, d'Anna C, de Maria M, Lagalla R, et al. Static magnetic fields generated by a 0.5 T MRI unit affects in vitro expression of activation markers and interleukin release in human peripheral blood mononuclear cells (PBMC). Int J Radiat Biol. 1999;75(4):457–63.PubMedCrossRef

48.

Pessina GP, Aldinucci C. Pulsed electromagnetic fields enhance the induction of cytokines by peripheral blood mononuclear cells challenged with phytohemagglutinin. Bioelectromagnetics. 1998;19(8):445–51.PubMedCrossRef

49.

Kleijn SD, Bouwens M, Verburg-van Kemenade BM, Cuppen JJ, Ferwerda G, Hermans PW. Extremely low frequency electromagnetic field exposure does not modulate toll-like receptor signaling in human peripheral blood mononuclear cells. Cytokine. 2011;54(1):43–50. doi:10.1016/j.cyto.2010.12.016.PubMedCrossRef

50.

Hefeneider SH, McCoy SL, Hausman FA, Christensen HL, Takahashi D, Perrin N, et al. Long-term effects of 60-Hz electric vs. magnetic fields on IL-1 and IL-2 activity in sheep. Bioelectromagnetics. 2001;22(3):170–7.PubMedCrossRef

51.

Hefeneider SH. Joint HVAC transmission EMF environmental study: final report on experiment 3. Portland: Bonneville Power Administration; 1994.

52.

Di Loreto S, Falone S, Caracciolo V, Sebastiani P, D'Alessandro A, Mirabilio A, et al. Fifty hertz extremely low-frequency magnetic field exposure elicits redox and trophic response in rat-cortical neurons. J Cell Physiol. 2009;219(2):334–43.PubMedCrossRef

53.

Frahm J, Lantow M, Lupke M, Weiss DG, Simkó M. Alteration in cellular functions in mouse macrophages after exposure to 50 Hz magnetic fields. J Cell Biochem. 2006;99(1):168–77.PubMedCrossRef

54.

Zhou J, Li C, Yao G, Chiang H, Chang Z. Gene expression of cytokine receptors in HL60 cells exposed to a 50 Hz magnetic field. Bioelectromagnetics. 2002;23(5):339–46.PubMedCrossRef

55.

Selmaoui B, Lambrozo J, Touitou Y. Endocrine functions in humans exposed to 50-Hz magnetic field. A circadian study of pituitary, thyroid and adrenal hormones. Life Sci. 1997;61:473–86.PubMedCrossRef

56.

Selmaoui B, Lambrozo J, Touitou Y. Assessment of nocturnal exposure to 50-Hz magnetic fields on the human circadian system. A comprehensive study of biochemical variables. Chronobiol Int. 1999;16(6):789–781.CrossRef

57.

Selmaoui B, Aymard N, Lambrozo J, Touitou Y. Evaluation of the nocturnal levels of urinary biogenic amines in men exposed overnight to magnetic field. Life Sci. 2003;73(24):3073–82.PubMedCrossRef

58.

Touitou Y, Lambrozo J, Camus F, Charbuy H. Magnetic fields and the melatonin hypothesis: a study of workers chronically exposed to 50-Hz magnetic fields. Am J Physiol Regul Integr Comp Physiol. 2003;284(6):R1529–35.PubMed

Title: Acute Exposure to 50-Hz Magnetic Fields Increases Interleukin-6 in Young Healthy Men
Authors: Brahim Selmaoui
Jacques Lambrozo
Linda Sackett-Lundeen
Erhard Haus
Yvan Touitou
Publication date: 01-12-2011
Publisher: Springer US
Published in: Journal of Clinical Immunology / Issue 6/2011
Print ISSN: 0271-9142
Electronic ISSN: 1573-2592
DOI: https://doi.org/10.1007/s10875-011-9558-y

ACC 2024 Congress Coverage

Heart Failure Video

At a glance: The ONWARDS insulin icodec trials

Springer Medicine

Acute Exposure to 50-Hz Magnetic Fields Increases Interleukin-6 in Young Healthy Men

Abstract

ACC 2024 Congress Coverage

Year in Review: Heart failure and cardiomyopathies

Semaglutide benefits people with type 2 diabetes and obesity-related heart failure

Incentivised to exercise

New intervention for STEMI-related cardiogenic shock

» View more highlights on the ACC 2024 congress hub page

At a glance: The ONWARDS insulin icodec trials

Springer Medicine

Abstract

Please log in to get access to this content

Other articles of this Issue 6/2011

Transgenic Mice that Overexpress Human IL-15 in Enterocytes Recapitulate Both B and T Cell-Mediated Pathologic Manifestations of Celiac Disease

Association of IRF5 Polymorphisms with Susceptibility to Hemophagocytic Lymphohistiocytosis in Children

Developmental, Malignancy-Related, and Cross-Species Analysis of Eosinophil, Mast Cell, and Basophil Siglec-8 Expression

Cause of Death in Neonates with Inconclusive or Abnormal T-cell Receptor Excision Circle Assays on Newborn Screening

Immunomodulative Efficacy of Bone Marrow-Derived Mesenchymal Stem Cells Cultured in Human Platelet Lysate

Mutations in the ELANE Gene are Associated with Development of Periodontitis in Patients with Severe Congenital Neutropenia

ACC 2024 Congress Coverage

Year in Review: Heart failure and cardiomyopathies

Semaglutide benefits people with type 2 diabetes and obesity-related heart failure

Incentivised to exercise

New intervention for STEMI-related cardiogenic shock

» View more highlights on the ACC 2024 congress hub page